3SBio Inc., of Shenyang, China, appointed David Chen executive vice president and chief operating officer.
Arbor Vita Corp., of Sunnyvale, Calif., named Linda McAllister vice president of diagnostics.
Aureon Laboratories Inc., of Yonkers, N.Y., appointed Ana I. Stancic chief financial officer.
Avalon Pharmaceuticals Inc., of Germantown, Md., named Philip Frost to its board of directors.
Barrier Therapeutics Inc., of Princeton, N.J., named Dennis P. Reilly vice president of finance and principal accounting officer.
Bionovo Inc., of Emeryville, Calif., appointed George Butler and Louis Drapeau to its board of directors.
Biophan Technologies Inc., of Pittsford, N.Y., named John H. Bowers senior technologist.
Cytomedix Inc., of Rockville, Md., appointed Martin P. Rosendale executive vice president and chief operating officer.
Gene Express Inc., of Toledo, Ohio, named James L. Mulshine to its scientific advisory board.
Hana Biosciences, of South San Francisco, appointed Paul V. Maier to its board of directors.
Icagen Inc., of Research Triangle Park, N.C., appointed Richard Katz executive vice president of finance and corporate development and chief financial officer and Douglas Krafte vice president of biology and scientific affairs. The company also named Mark Suto vice president of chemical and pharmaceutical sciences.
Isolagen Inc., of Exton, Pa., appointed Todd Greenspan chief financial officer and John Maslowski vice president of operations.
MacroChem Corp., of Wellesley Hills, Mass., named David P. Luci chief financial officer.
Multisorb Technologies, of Warrington, UK, named Laurent Rozier business development representative in healthcare packaging for central and southern Europe.
Nova Biosource Fuels Inc., of Houston, named Fred Zeidman interim president.
Parexel International Corp., of Boston, appointed Jacque Fisher vice president and general manager of its Medical Communications Services business.
Pharmacopeia Inc., of Cranbury, N.J., promoted Rene Belder to senior vice president of clinical and regulatory affairs and S. David Kimball to senior vice president of chemistry and preclinical chemical development.
Pressure BioSciences Inc., of South Easton, Mass., named Matthew B. Potter vice president of sales.
ProtoKinetix Inc., of Vancouver, British Columbia, appointed Randy Anderson vice president of government affairs.
Senetek Plc, of Napa, Calif., named Michael Campagnoli executive director and Phillip Rose consultant for sales and marketing. The company also appointed Marjorie Hays vice president of communications.
ThermoGenesis Corp., of Rancho Cordova, Calif., appointed Mahendra Rao to its board of directors.
Vaccinex Inc., of Rochester, N.Y., named John E. Leonard to its scientific advisory board.
Vitae Pharmaceuticals Inc., of Fort Washington, Pa., named Richard Gregg chief science officer.
WaferGen Biosystems Inc., of Fremont, Calif., promoted Kumar Kastury to vice president of assay development and John McEntee to associate vice president of engineering.
XOMA Ltd., of Berkeley, Calif., appointed Mary L. Anderson vice president of business development.
Znomics Inc., of Portland, Ore., appointed Stephane Berghmans director of drug discovery.